Akademska digitalna zbirka SLovenije - logo
E-resources
Peer reviewed Open access
  • A Placebo-Controlled Trial ...
    Newsome, Philip N; Buchholtz, Kristine; Cusi, Kenneth; Linder, Martin; Okanoue, Takeshi; Ratziu, Vlad; Sanyal, Arun J; Sejling, Anne-Sophie; Harrison, Stephen A

    New England journal of medicine/˜The œNew England journal of medicine, 03/2021, Volume: 384, Issue: 12
    Journal Article

    Patients with nonalcoholic steatohepatitis were randomly assigned to receive subcutaneous semaglutide or placebo. The incidence of NASH resolution was significantly higher with semaglutide than with placebo, but the between-group difference in the incidence of an improvement in fibrosis stage was not significant.